Literature DB >> 11029998

Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

L H Bachmann1, I Lewis, R Allen, J R Schwebke, L C Leviton, H A Siegal, E W Hook.   

Abstract

OBJECTIVES: We evaluated the prevalence of gonorrhea, chlamydia, trichomoniasis, and syphilis in patients entering residential drug treatment.
METHODS: Data on sexual and substance abuse histories were collected. Participants provided specimens for chlamydia and gonorrhea ligase chain reaction testing. Trichomonas vaginalis culture, and syphilis serologic testing.
RESULTS: Of 311 patients, crack cocaine use was reported by 67% and multisubstance use was reported by 71%. Sexually transmitted disease (STD) risk behaviors were common. The prevalence of infection was as follows: Chlamydia trachomatis, 2.3%; Neisseria gonorrhoeae, 1.6%; trichomoniasis, 43%; and syphilis, 6%.
CONCLUSIONS: STD counseling and screening may be a useful adjunct to inpatient drug treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11029998      PMCID: PMC1446369          DOI: 10.2105/ajph.90.10.1615

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  26 in total

1.  Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and HIV infection among drug users attending an STD/HIV prevention and needle-exchange program in Quebec City, Canada.

Authors:  C Poulin; M Alary; F Bernier; J Ringuet; J R Joly
Journal:  Sex Transm Dis       Date:  1999-08       Impact factor: 2.830

2.  Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.

Authors:  J R Schwebke; S L Hillier; J D Sobel; J A McGregor; R L Sweet
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

3.  Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis.

Authors:  J R Schwebke; S C Morgan; G B Pinson
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora.

Authors:  J R Schwebke; S C Morgan; H L Weiss
Journal:  Sex Transm Dis       Date:  1997-04       Impact factor: 2.830

5.  Immunoglobulin E and the eczema-asthma syndrome in early childhood.

Authors:  R R Gordon; D A Noble; A M Ward; R Allen
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

6.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening.

Authors:  M Buimer; G J van Doornum; S Ching; P G Peerbooms; P K Plier; D Ram; H H Lee
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Diagnosis of Neisseria gonorrhoeae infections in women by using the ligase chain reaction on patient-obtained vaginal swabs.

Authors:  E W Hook; S F Ching; J Stephens; K F Hardy; K R Smith; H H Lee
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

8.  Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic.

Authors:  K R Smith; S Ching; H Lee; Y Ohhashi; H Y Hu; H C Fisher; E W Hook
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

9.  Accuracy of immunization histories provided by adults accompanying preschool children to a pediatric emergency department.

Authors:  K P Goldstein; F J Kviz; R S Daum
Journal:  JAMA       Date:  1993-11-10       Impact factor: 56.272

10.  Plasma cell endometritis in women with symptomatic bacterial vaginosis.

Authors:  A P Korn; G Bolan; N Padian; M Ohm-Smith; J Schachter; D V Landers
Journal:  Obstet Gynecol       Date:  1995-03       Impact factor: 7.661

View more
  17 in total

Review 1.  Trichomoniasis.

Authors:  Jane R Schwebke; Donald Burgess
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 2.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

3.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

4.  Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.

Authors:  Erick G Guerrero; Julie A Cederbaum
Journal:  Int J Drug Policy       Date:  2010-10-20

Review 5.  "Bundling" HIV prevention: integrating services to promote synergistic gain.

Authors:  Jeannette R Ickovics
Journal:  Prev Med       Date:  2007-09-29       Impact factor: 4.018

6.  States and substance abuse treatment programs: funding and guidelines for infection-related services.

Authors:  Steven Kritz; Lawrence S Brown; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; Patricia Novo; John Rotrosen
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

7.  HIV/STI Risk Behavior of Drug Court Participants.

Authors:  Angela A Robertson; Janet S St Lawrence; D Lee McCluskey
Journal:  J Offender Rehabil       Date:  2012-07

8.  Screening for sexually transmitted infections in substance abuse treatment programs.

Authors:  Jane M Liebschutz; Erin P Finley; Phillip G Braslins; Demian Christiansen; Nicholas J Horton; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2003-05-01       Impact factor: 4.492

9.  Screening for sexually transmitted infections at a DeAddictions service in south India.

Authors:  Michael P Carey; V Ravi; Prabha S Chandra; Anita Desai; Dan J Neal
Journal:  Drug Alcohol Depend       Date:  2005-09-22       Impact factor: 4.492

Review 10.  Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis.

Authors:  Hajar Ziaei Hezarjaribi; Mahdi Fakhar; Azar Shokri; Saeed Hosseini Teshnizi; Azita Sadough; Mahbobeh Taghavi
Journal:  Parasitol Res       Date:  2015-03-04       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.